~~<i id='0C80C39196'><strike id='0C80C39196'><tt id='0C80C39196'><pre id='0C80C39196'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：knowledge 2025-09-02 11:48:46 - browse：36739

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： AdventHealth escalates lawsuit against insurance vendor Multiplan

leisure time

knowledge

entertainment

hotspot

entertainment

MollyFerguson/STATIttookAnavexLifeSciencessevenmonthstofinallyacknowledgethefailureofalate-stageclin

WSS

What it's like to live with paralysis for one psychologist

The battle over 'scope creep' and who gets to be called 'doctor'

UHS says company favors patients whose insurance pays more

3 trends to watch in health tech's hiring outlook for 2024

Why psychiatrists like me stop taking insurance

U.K. sequencing study surfaces new findings about tumor DNA

leisure time

entertainment

leisure time

What does generative AI mean for health care? We asked experts

Democrats decry new health bill for going easy on private equity

Jerome Adams on the need for new antivirals for Covid

New weight loss drugs work. But how can they best be used?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Democrats decry new health bill for going easy on private equity

In age of alternative facts, a scholarly course on calling out crap

JPM: CVS says Medicare Advantage patients are impacting profits

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why patients can’t get everything they want on drug pricing

knowledge

Dems pitch expanding Medicare power to negotiate drug prices

A new crop of companies is reshaping the health data economy

The FDA must approve intranasal treatments for anaphylaxis

Feng Zhang CRISPR delivery startup lays off quarter of staff

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Truvian presents data for its desktop blood

entertainment

hotspot

entertainment

entertainment